You are required to be logged in to access the full website
Click here if you have forgotten your username or password
16 November 2026 - Biopharmaceutical company Aelis Farma (Euronext: AELIS) announced on Monday that it has received a second positive recommendation from the Independent Data Monitoring Committee (IDMC) following its review of the Phase 2b trial of A...
16 November 2026 - CARsgen Therapeutics Holdings Limited (HK:2171), a Chinese developer of innovative CAR T-cell therapies, announced on Saturday that satricabtagene autoleucel (satri-cel, product code: CT041), an autologous CAR T-cell therapy produc...
16 November 2026 - Ambrosia Biosciences Inc, a drug discovery company developing next-generation oral small molecule therapies for obesity and other metabolic disorders, on Sunday announced nonclinical data in two poster presentations at The Obesity ...
16 November 2026 - Precision medicine oncology company IDEAYA Biosciences Inc (Nasdaq:IDYA) on Sunday announced the development candidate nomination of IDE101, a potential first-in-class dual cyclin-dependent kinase (CDK) inhibitor designed to addres...
16 November 2026 - Biopharmaceutical company Specialised Therapeutics announced on Sunday that the Thailand Food and Drug Administration has approved YONDELIS (trabectedin) for the treatment of adult patients with advanced soft tissue sarcoma (STS).T...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe